Every recall we track for Aadi Bioscience — 1 in all — plus the complaints and injury reports the public filed about them.
Aadi Bioscience recalls Fyarro (sirolimus protein-bound particles for injectable suspension) due to failed stability specifications. This may affect drug safety and efficacy.
